Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry
Lori B. Daniels,Nicholas Phreaner,David D. Berg,Erin A. Bohula,Sunit-Preet Chaudhry,Christopher B. Fordyce,Michael J. Goldfarb,Jason N. Katz,Benjamin B. Kenigsberg,Patrick R. Lawler,Miguel A. Martillo Correa,Alexander I. Papolos,Robert O. Roswell,Shashank S. Sinha,Sean van Diepen,Jeong-Gun Park,David A. Morrow,on behalf of the Critical Care Cardiology Trials Network Investigators
DOI: https://doi.org/10.1161/circoutcomes.123.010614
2024-06-22
Circulation Cardiovascular Quality and Outcomes
Abstract:Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Sex disparities exist in the management and outcomes of various cardiovascular diseases. However, little is known about sex differences in cardiogenic shock (CS). We sought to assess sex-related differences in the characteristics, resource utilization, and outcomes of patients with CS.METHODS:The Critical Care Cardiology Trials Network is a multicenter registry of advanced cardiac intensive care units (CICUs) in North America. Between 2018 and 2022, each center (N=35) contributed annual 2-month snapshots of consecutive CICU admissions. Patients with CS were stratified as either CS after acute myocardial infarction or heart failure–related CS (HF-CS). Multivariable logistic regression was used for analyses.RESULTS:Of the 22 869 admissions in the overall population, 4505 (20%) had CS. Among 3923 patients with CS due to ventricular failure (32% female), 1235 (31%) had CS after acute myocardial infarction and 2688 (69%) had HF-CS. Median sequential organ failure assessment scores did not differ by sex. Women with HF-CS had shorter CICU lengths of stay (4.5 versus 5.4 days;P<0.0001) and shorter overall lengths of hospital stay (10.9 versus 12.8 days;P<0.0001) than men. Women with HF-CS were less likely to receive pulmonary artery catheters (50% versus 55%;P<0.01) and mechanical circulatory support (26% versus 34%;P<0.0001) compared with men. Women with HF-CS had higher in-hospital mortality than men, even after adjusting for age, illness severity, and comorbidities (34% versus 23%; odds ratio, 1.76 [95% CI, 1.42–2.17]). In contrast, there were no significant sex differences in utilization of advanced CICU monitoring and interventions, or mortality, among patients with CS after acute myocardial infarction.CONCLUSIONS:Women with HF-CS had lower use of pulmonary artery catheters and mechanical circulatory support, shorter CICU lengths of stay, and higher in-hospital mortality than men, even after accounting for age, illness severity, and comorbidities. These data highlight the need to identify underlying reasons driving the differences in treatment decisions, so outcomes gaps in HF-CS can be understood and eliminated.
cardiac & cardiovascular systems